Ascentage Pharma Group International (NASDAQ:AAPG – Get Free Report)’s share price traded up 7.3% on Friday . The stock traded as high as $18.99 and last traded at $18.99. 45,477 shares traded hands during trading, a decline of 45% from the average session volume of 82,246 shares. The stock had previously closed at $17.70.
Wall Street Analyst Weigh In
Separately, JPMorgan Chase & Co. started coverage on Ascentage Pharma Group International in a research note on Thursday, March 27th. They issued an “overweight” rating for the company.
Get Our Latest Research Report on AAPG
Ascentage Pharma Group International Stock Performance
Ascentage Pharma Group International Company Profile
Ascentage Pharma Group International Co, Ltd. is a clinical-stage biotechnology company. It engages in the development of novel therapies for cancers, hepatitis B virus, or HBV, and age-related diseases. The company was founded by Da Jun Yang, Wang Shao Meng and Ming Guo in May 2009 and is headquartered in Suzhou, China.
See Also
- Five stocks we like better than Ascentage Pharma Group International
- What is Insider Trading? What You Can Learn from Insider Trading
- Robinhood Strategies Could Be a Game-Changer for Young Investors
- How to Most Effectively Use the MarketBeat Earnings Screener
- Are These 3 Retail Stocks Oversold or Really in Trouble?
- Why Invest in High-Yield Dividend Stocks?
- IONQ & RGTI Join DARPA Quantum Initiative: High Stakes Are Ahead
Receive News & Ratings for Ascentage Pharma Group International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ascentage Pharma Group International and related companies with MarketBeat.com's FREE daily email newsletter.
